|
|
|
| OMB APPROVAL |
| OMB Number: |
|
3235-0116 |
| Expires: |
|
December 31, 2026 |
| Estimated average burden |
| hours per response |
|
8.7 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September, 2025.
Commission File Number 001-41670
Apollomics, Inc.
(Translation of registrant’s name into English)
989 E. Hillsdale Blvd., Suite 220, Foster City, California 94404
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form
20-F or Form 40-F.
☒ Form
20-F ☐ Form 40-F
Press Releases
On September 22, 2025, Apollomics Inc. (“Apollomics” or the “Company”) issued a press release announcing its receipt of a letter
from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) indicating that unless the Company requests an appeal, Nasdaq will delist the Company’s securities under Nasdaq
Listing Rule 5101 based on the Staff’s belief that Apollomics is now only a “public shell”. As discussed in greater detail in the press release, the Company disagrees with the Staff and will appeal. The press release also provides
certain updates with respect to the Company’s ongoing operations.
On September 25, 2025, Apollomics issued another press release announcing
its completion of the filing of its application on September 23, 2025 to appeal the delisting notification it had earlier received from the Staff of Nasdaq. Additionally, Apollomics announced that in connection with the Writ and Statement of
Claim issued in the Grand Court of the Cayman Islands by one investment manager for two minority investors in the Company dated July 22, 2024 (the “Cayman Litigation”), the Grand Court of the Cayman Islands has issued a consent
order via consent of all parties that all further steps in these proceedings of the Cayman Litigation are stayed from and after September 12, 2025, until further order from such court.
The press releases are attached here as Exhibit 99.1 and 99.2.
EXHIBITS
|
|
|
Exhibit
No. |
|
Description |
|
|
| 99.1 |
|
Press Release - Apollomics Announces Receipt of Delisting Determination Letter from Nasdaq |
|
|
| 99.2 |
|
Press Release - Apollomics Announces Completion of Filing of Appeal of Nasdaq Delisting Order |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
/s/ Peter Lin |
| Date September 25, 2025 |
|
|
|
|
|
|
|
|
(Signature)* |
|
|
|
|
|
|
|
Peter Lin, Chief Financial Officer |
|
|
|
|
* Print the name and title under the signature of the signing officer. |
|
|
|
| SEC 1815 (07-22) |
|
Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number. |
